-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

901.O2.6 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Optimizing Classical Hematology Care

Symposia: Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Bleeding and Clotting, Bleeding disorders, Adult, Research, Artificial intelligence (AI), Clinical Practice (Health Services and Quality), Hemophilia, Translational Research, Epidemiology, Assays, Clinical Research, Health outcomes research, Thromboembolism, Education, Health disparities research, Diversity, Equity, and Inclusion (DEI), Pediatric, Diseases, Thrombocytopenias, Thrombotic disorders, Treatment Considerations, Non-Biological therapies, Technology and Procedures, Study Population, Human, Natural language processing
Saturday, December 7, 2024: 12:00 PM-1:30 PM
Room 31 (San Diego Convention Center)
Moderators:
Kelly Bush, MD, ARRAY(0xef0e450) and Camila Masias, MD, MPH,
Disclosures:
No relevant conflicts of interest to declare.
12:00 PM

Samira Glaeser-Khan, BS1*, Rhys Richmond, BS1*, Satoko Ito, MD, PhD2, Robert D Bona, MD2, Harlan M. Krumholz, MD, SM3*, Adam Cuker, MD MS4 and George Goshua, MD, MSc3,5

1Yale School of Medicine, New Haven, CT
2Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
3Center for Outcomes Research and Evaluation, Yale University and Yale New Haven Hospital, New Haven, CT
4Department of Medicine and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
5Hematology-Oncology & Yale CORE, Yale School of Medicine & Yale Cancer Center, New Haven, CT

12:15 PM

Jordan K Schaefer, MD, MSc1, Naina Chipalkatti, MD2, Linda Bashaw2*, Adam Davie, MD2*, Joelle Ellis1*, Molly Harrod, PhD3*, Jacob E Kurlander, MD, MS4*, Christine Medaugh, MD5*, Rebeca Packard, MS, RN6*, Corey Powell, PhD7*, Suman L Sood, MD, MSCE1, Elizabeth Spranger2*, Sarah Vordenberg, PharmD, MPH8* and Geoffrey D Barnes, MD, MSc9*

1Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
2Department of Internal Medicine, University of Michigan, Ann Arbor, MI
3VA Ann Arbor Healthcare System, Ann Arbor, MI
4Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
5Department of Family Medicine, University of Michigan, Ann Arbor, MI
6Health Information Technology & Services, University of Michigan, Ann Arbor, MI
7Consulting for Statistics, Computing & Analytics Research, University of Michigan, Ann Arbor, MI
8Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI
9Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI

12:30 PM

Joud El Dick, MD1, Jackson Hoesley, MD2*, Rance C. Siniard, MD3*, Laura J. Taylor, MT4*, Cari E. Reed, MT4*, Marisa B. Marques, MD3* and Jori E. May, MD1

1Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
2Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
3Department of Pathology, Division of Laboratory Medicine, University of Alabama At Birmingham, Birmingham, AL
4Special Coagulation Laboratory, University of Alabama at Birmingham, Birmingham, AL

12:45 PM

Ahmad Nassar, MBBS1, Ryan Sun, MD2*, Danny Hadidi3*, Margaret E Wright4*, Subhash K Kolar Rajanna5*, Sargam Kapoor, MBBS6, Thomas L. Ortel, MD, PhD7 and John G Quigley8

1University of Illinois Chicago, Chicago, IL
2Division of Hematology and Oncology, Department of Medicine, University of Illinois Chicago, Chicago, IL, Chicago, IL
3Department of Internal Medicine, St. Luke's Hospital, Chesterfield, MO
4University of Illinois Cancer Center, Chicago, IL
5Center for Clinical and Translational Science, University of Illinois Chicago, Chicago
6Division of Hematology, Department of Medicine, Duke University, Durham, NC
7Division of Hematology, Duke University School of Medicine, Durham, NC
8Division of Hematology/Oncology, University of Illinois, Chicago, Chicago, IL

1:00 PM

Ang Li, MD, MS1, Omid Jafari, PhD1*, Shengling Ma, MD, PhD2, Arash Maghsoudi3*, Barbara D Lam, MD4, Justine Ryu, MD5, Jun Yang Jiang, MD6*, Mrinal Ranjan, MPH1*, Emily Zhou7*, Raka Bandyo, MS8*, Bo Peng9*, Christopher I Amos1*, Nathanael R. Fillmore, PhD10,11*, Abiodun O. Oluyomi12* and Jennifer La11*

1Baylor College of Medicine, Houston, TX
2Section of Hematology-Oncology, Baylor College of Medicine, HOUSTON, TX
3Health Services Research Department of Medicine, Baylor College of Medicine, Houston, TX
4Division of Hematology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA
5Section of Hematology, Yale University School of Medicine, New Haven, CT
6Section of Hematology-Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX
7McGovern Medical School, University of Texas Health Science Center, Houston, TX
8Harris Health System, Houston, TX
9Baylor College of Medicine, houston, TX
10Harvard Medical School, Boston, MA
11VA Boston Healthcare System, Boston, MA
12Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX

1:15 PM

Lauren E. Merz, MD, MSc1,2, Satoko Ito, MD, PhD3, Kelly J. Walkovich, MD4,5, Maureen Achebe, MD6*, Nathalie Van Havre, MD, MS, FRACP7, Patricia Frustace7 and George Goshua, MD, MSc8

1Division of Hematology/Oncology, Mass General Brigham, Boston, MA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA
3Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
4University of Michigan, Ann Arbor, MI
5C.S. Mott Children’s Hospital, University of Michigan, Ann Arbor, MI
6Brigham and Women's Hospital, Boston, MA
7American Society of Hematology, Washington, DC
8Hematology-Oncology & Yale CORE, Yale School of Medicine & Yale Cancer Center, New Haven, CT

*signifies non-member of ASH